Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritisJasper J. Haringman, Paul P. Tak, Daniëlle M. Gerlag et al.|Annals of the Rheumatic Diseases|2004Cited by 464
Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI studyDaniëlle M. Gerlag, Paul P. Tak, M. Safy et al.|Annals of the Rheumatic Diseases|2018Cited by 289
A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritisJasper J. Haringman, Paul P. Tak, François Legay et al.|Arthritis & Rheumatism|2006Cited by 255
Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritisDaniëlle M. Gerlag, Paul P. Tak, Jasper J. Haringman et al.|Arthritis & Rheumatism|2004Cited by 155
Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarkerCarla A. Wijbrandts, Paul P. Tak, Clarissa E. Vergunst et al.|Arthritis & Rheumatism|2007Cited by 114